(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 5.57% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.54%.
Bruker's revenue in 2024 is $3,241,300,000.On average, 5 Wall Street analysts forecast BRKR's revenue for 2024 to be $508,367,718,837, with the lowest BRKR revenue forecast at $508,187,620,128, and the highest BRKR revenue forecast at $508,566,615,728. On average, 5 Wall Street analysts forecast BRKR's revenue for 2025 to be $546,541,065,259, with the lowest BRKR revenue forecast at $544,889,554,032, and the highest BRKR revenue forecast at $548,952,841,659.
In 2026, BRKR is forecast to generate $588,347,311,903 in revenue, with the lowest revenue forecast at $581,667,287,056 and the highest revenue forecast at $593,944,015,728.